In this episode of Updates in Anesthesiology, Dr. Hadzic discusses a 2025 RAPM study comparing the classic lidocaine–bupivacaine mix to 0.5% bupivacaine alone for infraclavicular blocks. The results? Mixing speeds onset but slashes duration by nearly 14 hours. Tune in to learn why faster isn’t always better, how adjuvants like dexamethasone already optimize your block, and when it’s finally time to ditch the mix.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠ 

Instagram- ⁠⁠instagram.com/nysora.inc/ ⁠⁠

LinkedIN- ⁠⁠linkedin.com/company/nysora-inc/⁠⁠ 

Facebook- ⁠⁠facebook.com/nysora⁠⁠ 

Twitter- ⁠⁠x.com/nysora⁠⁠ 

TikTok- ⁠⁠tiktok.com/@nysora_inc⁠⁠ 

--------------------------------------------------------- ⁠⁠

#nysora⁠⁠ ⁠⁠#regionalanesthesia⁠⁠ ⁠⁠#anesthesia⁠⁠

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

In this episode of Updates in Anesthesiology, Dr. Hadzic discusses a 2025 review that reshapes how we manage bleeding in children. From restrictive transfusion thresholds and viscoelastic testing to the revival of whole blood and smarter use of TXA, pediatric hemostasis is entering a new era. Tune in to learn why kids aren’t just “small adults,” how to individualize transfusion decisions, and the five steps to safer blood management in your next pediatric case.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠ 

Instagram- ⁠⁠instagram.com/nysora.inc/ ⁠⁠

LinkedIN- ⁠⁠linkedin.com/company/nysora-inc/⁠⁠ 

Facebook- ⁠⁠facebook.com/nysora⁠⁠ 

Twitter- ⁠⁠x.com/nysora⁠⁠ 

TikTok- ⁠⁠tiktok.com/@nysora_inc⁠⁠ 

--------------------------------------------------------- ⁠⁠

#nysora⁠⁠ ⁠⁠#regionalanesthesia⁠⁠ ⁠⁠#anesthesia⁠⁠

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

In this episode of Updates in Anesthesiology, Dr. Hadzic discusses the main findings from a 2025 BJA review by Tinsley et al. The study reported how to manage non-insulin diabetes medicines in the perioperative period safely. From metformin’s misunderstood safety profile to the hidden risks of SGLT-2 inhibitors and GLP-1 agonists, you’ll learn which drugs to hold, which to continue, and how to prevent complications like euglycaemic DKA and aspiration. 

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠ 

Instagram- ⁠⁠instagram.com/nysora.inc/ ⁠⁠

LinkedIN- ⁠⁠linkedin.com/company/nysora-inc/⁠⁠ 

Facebook- ⁠⁠facebook.com/nysora⁠⁠ 

Twitter- ⁠⁠x.com/nysora⁠⁠ 

TikTok- ⁠⁠tiktok.com/@nysora_inc⁠⁠ 

--------------------------------------------------------- ⁠⁠

#nysora⁠⁠ ⁠⁠#regionalanesthesia⁠⁠ ⁠⁠#anesthesia⁠⁠

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

A 2025 Anesthesiology meta-analysis shows that the best pain control after total hip arthroplasty comes from combining regional anesthesia with local infiltration analgesia (LIA). While LIA alone is effective, adding a quadratus lumborum or pericapsular nerve group (PENG) block significantly improves pain relief, reduces opioid use, and preserves mobility. The takeaway: stop choosing between techniques — regional + local is the new gold standard for hip surgery analgesia.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠ 

Instagram- ⁠⁠instagram.com/nysora.inc/ ⁠⁠

LinkedIN- ⁠⁠linkedin.com/company/nysora-inc/⁠⁠ 

Facebook- ⁠⁠facebook.com/nysora⁠⁠ 

Twitter- ⁠⁠x.com/nysora⁠⁠ 

TikTok- ⁠⁠tiktok.com/@nysora_inc⁠⁠ 

--------------------------------------------------------- ⁠⁠

#nysora⁠⁠ ⁠⁠#regionalanesthesia⁠⁠ ⁠⁠#anesthesia⁠⁠

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

In this episode of Updates in Anesthesiology, Dr. Hadzic unpacks a landmark 2025 study, which challenges the long-held belief that intraoperative hypotension (MAP < 65 mm Hg) contributes to postoperative delirium in older adults. With nearly 40,000 patients analyzed and no association found, it’s time to rethink reflexively chasing MAP thresholds. Tune in to hear why blood pressure might not be the villain we thought, and what really matters for preventing POD.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠ 

Instagram- ⁠⁠instagram.com/nysora.inc/ ⁠⁠

LinkedIN- ⁠⁠linkedin.com/company/nysora-inc/⁠⁠ 

Facebook- ⁠⁠facebook.com/nysora⁠⁠ 

Twitter- ⁠⁠x.com/nysora⁠⁠ 

TikTok- ⁠⁠tiktok.com/@nysora_inc⁠⁠ 

--------------------------------------------------------- ⁠⁠

#nysora⁠⁠ ⁠⁠#regionalanesthesia⁠⁠ ⁠⁠#anesthesia⁠⁠

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

In this episode of Updates in Anesthesiology, Dr. Hadzic delves into a 2025 study, which analyzed over 53,000 surgical cases. The key finding? Neuromuscular blockers increase the risk of postoperative delirium in older adults, unless they’re properly reversed. Whether you use sugammadex or neostigmine, reversal agents significantly reduce this risk. Tune in to hear what this means for your clinical practice and how small changes in perioperative management can make a significant impact on cognitive outcomes.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠ 

Instagram- ⁠⁠instagram.com/nysora.inc/ ⁠⁠

LinkedIN- ⁠⁠linkedin.com/company/nysora-inc/⁠⁠ 

Facebook- ⁠⁠facebook.com/nysora⁠⁠ 

Twitter- ⁠⁠x.com/nysora⁠⁠ 

TikTok- ⁠⁠tiktok.com/@nysora_inc⁠⁠ 

--------------------------------------------------------- ⁠⁠

#nysora⁠⁠ ⁠⁠#regionalanesthesia⁠⁠ ⁠⁠#anesthesia⁠⁠

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

In this episode of Updates in Anesthesiology, Dr. Hadzic unpacks the latest evidence on pharmacologic agents for perioperative cardioprotection in noncardiac surgery. From beta-blockers and statins to the evolving debate around RAAS inhibitors and aspirin, we cover what works, what doesn’t, and what’s still unclear. Plus, we discuss whether tighter blood pressure control or postoperative therapy intensification makes a difference. Tune in for practical, evidence-based takeaways to improve cardiac outcomes in your surgical patients.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠ 

Instagram- ⁠⁠instagram.com/nysora.inc/ ⁠⁠

LinkedIN- ⁠⁠linkedin.com/company/nysora-inc/⁠⁠ 

Facebook- ⁠⁠facebook.com/nysora⁠⁠ 

Twitter- ⁠⁠x.com/nysora⁠⁠ 

TikTok- ⁠⁠tiktok.com/@nysora_inc⁠⁠ 

--------------------------------------------------------- ⁠⁠

#nysora⁠⁠ ⁠⁠#regionalanesthesia⁠⁠ ⁠⁠#anesthesia⁠⁠

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

In this episode, Dr. Hadzic discusses the main findings from a new study from the British Journal of Anaesthesia (2025). The study reported that 1 in 4 children having noncardiac surgery has preoperative anemia, and that both anemia and transfusion independently, and especially together, increase 30-day mortality and complications. Despite strong global guidelines for blood management and anesthesia care in adults, pediatric blood management remains under-implemented. Learn how this data can transform your pre-op protocols, and what steps you can take right now to improve pediatric surgical outcomes.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠ 

Instagram- ⁠⁠instagram.com/nysora.inc/ ⁠⁠

LinkedIN- ⁠⁠linkedin.com/company/nysora-inc/⁠⁠ 

Facebook- ⁠⁠facebook.com/nysora⁠⁠ 

Twitter- ⁠⁠x.com/nysora⁠⁠ 

TikTok- ⁠⁠tiktok.com/@nysora_inc⁠⁠ 

--------------------------------------------------------- ⁠⁠

#nysora⁠⁠ ⁠⁠#regionalanesthesia⁠⁠ ⁠⁠#anesthesia⁠⁠

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

In this episode of UPDATES IN ANESTHESIOLOGY, Dr. Hadzic reviews a 2025 paper from Anesthesiology on managing obstetric anesthesia for patients with diabetes. From prelabor planning to postpartum glucose shifts, this episode covers everything you need to provide safe and effective anesthesia care for this growing population of high-risk parturients.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠ 

Instagram- ⁠⁠instagram.com/nysora.inc/ ⁠⁠

LinkedIN- ⁠⁠linkedin.com/company/nysora-inc/⁠⁠ 

Facebook- ⁠⁠facebook.com/nysora⁠⁠ 

Twitter- ⁠⁠x.com/nysora⁠⁠ 

TikTok- ⁠⁠tiktok.com/@nysora_inc⁠⁠ 

--------------------------------------------------------- ⁠⁠

#nysora⁠⁠ ⁠⁠#regionalanesthesia⁠⁠ ⁠⁠#anesthesia⁠⁠

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

 In this episode of the NYSORA Podcast: Updates in Anesthesiology, Dr. Hadzic breaks down what anesthesiologists need to know about using AI in clinical practice. We cover recent studies showing where AI like ChatGPT performs well (like data analysis) — and where it can be risky, especially in complex patient cases. You’ll also learn how NYSORA’s Anesthesia Assistant App, powered by Maia, gives you fast, reliable answers at the bedside—built on peer-reviewed content and reviewed by experts.
 What you’ll get:

• When to trust AI—and when not to
• How NYSORA’s app supports safe, informed decisions
• Real tips you can apply in practice today

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠ 

Instagram- ⁠⁠instagram.com/nysora.inc/ ⁠⁠

LinkedIn- ⁠⁠linkedin.com/company/nysora-inc/⁠⁠ 

Facebook- ⁠⁠facebook.com/nysora⁠⁠ 

Twitter- ⁠⁠x.com/nysora⁠⁠ 

TikTok- ⁠⁠tiktok.com/@nysora_inc⁠⁠ 

--------------------------------------------------------- ⁠⁠

#nysora⁠⁠ ⁠⁠#regionalanesthesia⁠⁠ ⁠⁠#anesthesia⁠⁠

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.